Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-19

Clinical Trial Update: Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey

View source ↗

Summary

This clinical trial update summarizes results from a completed Turkish study assessing the time to initiating DMARD therapy and the actual work limitations expe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2012-09-19